Daniel J. Kass

Daniel J. Kass

University of Pittsburgh

H-index: 29

North America-United States

About Daniel J. Kass

Daniel J. Kass, With an exceptional h-index of 29 and a recent h-index of 26 (since 2020), a distinguished researcher at University of Pittsburgh, specializes in the field of Pulmonary.

His recent articles reflect a diverse array of research interests and contributions to the field:

Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis

Enhanced T Cell'Stem-ness' in Secondary Lymphoid Compartment of Patients With Idiopathic Pulmonary Fibrosis

Archive of all online content

Epigenetic Aging and Environmental Exposures in Fibrotic Interstitial Lung Disease

PM2. 5 Associations With Lung Function in Patients With Pulmonary Sarcoidosis

Design of the STRIVE-IPF trial-study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis

The Association of Dyspnea and Oxygen Need as Measured by a Graded Treadmill Walk Test in Patients With Idiopathic Pulmonary Fibrosis

Daniel J. Kass Information

University

Position

Columbia University

Citations(all)

3418

Citations(since 2020)

2631

Cited By

1642

hIndex(all)

29

hIndex(since 2020)

26

i10Index(all)

57

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Daniel J. Kass Skills & Research Interests

Pulmonary

Top articles of Daniel J. Kass

Title

Journal

Author(s)

Publication Date

Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis

European Respiratory Journal

Harinath Bahudhanapati

Jiangning Tan

Rosa Marie Apel

Benjamin Seeliger

Jonas Schupp

...

2024/1/1

Enhanced T Cell'Stem-ness' in Secondary Lymphoid Compartment of Patients With Idiopathic Pulmonary Fibrosis

J Okereke

A Craig

Z Lakkis

M Abbas

J Sembrat

...

2024/5

Archive of all online content

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Y Wang

T Alam

K Hill-Harfe

AJ Lopez

CK Leung

...

2015/12

Epigenetic Aging and Environmental Exposures in Fibrotic Interstitial Lung Disease

GC Goobie

D Marinescu

AO Adegunsoye

C Carlsten

RL Clifford

...

2024/5

PM2. 5 Associations With Lung Function in Patients With Pulmonary Sarcoidosis

SE Kim

KF Gibson

D Kass

M Broerman

Y Zhang

...

2024/5

Design of the STRIVE-IPF trial-study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

BMC Pulmonary Medicine

Tejaswini Kulkarni

Gerard J Criner

Daniel J Kass

Ivan O Rosas

Mary Beth Scholand

...

2024/3/20

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis

Y Sakamachi

A Solis

CG Johnson

S Hussain

DN O'Dwyer

...

2022/5

The Association of Dyspnea and Oxygen Need as Measured by a Graded Treadmill Walk Test in Patients With Idiopathic Pulmonary Fibrosis

A Bshara

K Clark

KF Gibson

DJ Kass

2024/5

Nedd4L suppression in lung fibroblasts facilitates pathogenesis of lung fibrosis

Translational Research

Shuang Li

Qinmao Ye

Jianxin Wei

Sarah J Taleb

Heather Wang

...

2023/3/1

CXCL1 Is Highly Expressed in Secretory Cells and Correlates With Poor Outcomes in Patients With Idiopathic Pulmonary Fibrosis

H Bahudhanapati

D Kass

Y Zhang

A Prasse

2023/5

Plasma extracellular vesicle proteins as promising noninvasive biomarkers for diagnosis of idiopathic pulmonary fibrosis

Journal of Extracellular Biology

Raju SR Adduri

Kai Cai

Karen Velasco‐Alzate

Ravikiran Vasireddy

Jeffrey W Miller

...

2023/7

PM2. 5 and constituent component impacts on global DNA methylation in patients with idiopathic pulmonary fibrosis

Environmental Pollution

Gillian C Goobie

Xiaoyun Li

Christopher J Ryerson

Christopher Carlsten

Kerri A Johannson

...

2023/2/1

Pm2.5-induced DNA Methylation Alterations in Patients With Fibrotic Interstitial Lung Disease

GC Goobie

X Li

C Carlsten

KAM Johannson

D Marinescu

...

2023/5

Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity

European Respiratory Journal

Eleanor Valenzi

Harinath Bahudhanapati

Jiangning Tan

Tracy Tabib

Daniel I Sullivan

...

2023/7/1

CXCL6 Upregulates COL1A1 and COL1A2 mRNAs in IPF Fibroblasts by a Post-transcriptional Mechanism

H Bahudhanapati

J Tan

Y Zhang

SM Nouraie

D Kass

2023/5

MMP-7 Mediates PM2. 5 and Mortality Associations in Patients With Idiopathic Pulmonary Fibrosis

SE Kim

X Li

KF Gibson

D Kass

SM Nouraie

...

2023/5

Ambient Ultrafine Particulate Matter and Clinical Outcomes in Fibrotic Interstitial Lung Disease

American Journal of Respiratory and Critical Care Medicine

Gillian C Goobie

Provat K Saha

Christopher Carlsten

Kevin F Gibson

Kerri A Johannson

...

2023/11/29

Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants

American journal of respiratory and critical care medicine

Anna L Peljto

Rachel Z Blumhagen

Avram D Walts

Jonathan Cardwell

Julia Powers

...

2023/5/1

Differences in Exertional Oxygen Needs in Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD): Use of a Ramped Protocol Treadmill Exercise Test

K Clark

SM Nouraie

J Bon

FC Sciurba

D Kass

2023/5

Supplemental oxygen therapy in interstitial lung disease: a narrative review

Kristopher P Clark

Howard B Degenholtz

Kathleen O Lindell

Daniel J Kass

2023/11

See List of Professors in Daniel J. Kass University(University of Pittsburgh)